DanPET AB 
DanPET AB is a Swedish spin-out company from NeuroSearch A/S
- Dan Peters has >20 years of experience in pharmaceutical discovery and
development as a key scientific and management leader at NeuroSearch A/S - PET is a nuclear medicine technique for non-invasive, real-time 3D-imaging
of physiological processes in the brain and other organs - Development of best-in-class nicotinic alpha-7 PET ligands (11C-NS14492 and 18F-NS10743)
- 11C-NS14492 and 18F-NS10743 have potential for guiding diagnosis and treatment of Alzheimer’s Disease (Psychopharmacology (2006), 188(4), 509-520)
- High quality NET-PET ligands (11C-NS8880 and 18F-NS12137)
- SERT–PET ligands (11C-NS6417, 11C-NS9531 and 11C-NS9762)
- Broad IP portfolio within several classes with major focus on the EU and US-market
- DanPET owns IP-rights for the ligands mentioned above
Responsive Web Design powered by 